Sat Kartar Life Profit & Loss Annual

BSE: - | NSE: SATKARTAR | ISIN: INE0NB801022 | Sector: Biotechnology & Drugs

115.60 -5.45 (-4.50%)Updated : 19 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	179.38	149.99	119.00	78.93
Other Net	2.42	0.20	0.01	-0.06
Diluted Weighted Average Shares	1.57	1.57	1.57	1.57
Depreciation/ Amortization	3.37	1.30	1.33	1.32
Operating Income	21.32	12.93	8.91	4.04
Net Income	17.10	9.81	6.31	2.51
Income Availableto Com Excl Extra Ord	17.10	9.82	6.31	2.51
Other Operating Expenses Total	138.55	18.89	9.87	7.22
Net Income Before Taxes	23.22	13.15	8.59	3.44
Net Income After Taxes	17.10	9.81	6.31	2.51
Income Availableto Com Incl Extra Ord	17.10	9.82	6.31	2.51
Costof Revenue Total	14.47	9.00	9.03	4.96
Gross Profit	186.22	153.92	118.88	78.01
Interest Inc( Exp) Net- Non- Op Total	-0.53	0.03	-0.48	-0.51
Diluted Net Income	17.10	9.82	6.31	2.51
DPS- Common Stock Primary Issue	0.70	0.70	0.00	0.00
Provisionfor Income Taxes	6.11	3.34	2.29	0.94
period Type	-	-	-	-
Net Income Before Extra Items	17.10	9.81	6.31	2.51
Total Revenue	200.70	162.92	127.91	82.97
period Length	12.00	12.00	12.00	12.00
Revenue	200.70	162.92	127.91	82.97
Selling/ General/ Admin Expenses Total	22.98	120.81	98.77	65.43
Diluted Normalized EPS	10.86	6.23	3.93	1.61
Diluted EPS Excluding Extra Ord Items	10.86	6.23	4.00	1.59
Total Adjustmentsto Net Income	-	0.00	-	-
Gain( Loss)on Saleof Assets	-	0.00	0.15	-0.03
Unusual Expense( Income)	-	-	0.00	0.00